Neuroleptic malignant syndrome with trifluperidol.
In a case of NMS subsequent to administration of trifluperidol to a young man, the patient responded remarkably quickly to bromocriptine. The authors point out the deficiencies in the diagnostic criteria, which need further refinement for a better understanding of the syndrome.
Singh
S P
SP
Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Giridhar
C
C
Avasthi
A
A
D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000209:etiology*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D014272:Trifluperidol / Q000009:adverse effects* / Q000627:therapeutic use
D001971:Bromocriptine; D014272:Trifluperidol